Markets:

Overview

News

Currencies

International

Treasuries

Boston Scientific (NY:BSX)

42.83 -0.65 (-1.51%)

Streaming Delayed Price Updated: 2:45 PM EDT, Jun 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Boston Scientific

< Previous 1 2

...

23 24 25 26 27 28 29 30 Next >

Pipelines Are ESG ↗

May 02, 2021

ESG is in the eye of the beholder. My favorite is Lockheed Martin, a perennial member of the Dow Jones Sustainability Index. If building weapons to blow up people and property can be done in a...

Via Talk Markets

Topics Stocks

Pete Najarian Sees Unusual Option Activity In Boston Scientific And Las Vegas Sands ↗

April 30, 2021

On CNBC's "Fast Money Halftime Report," Pete Najarian gave some unusual option activity plays. Najarian sees unusual activity in: Boston Scientific (NYSE: BSX) May $...

Via Benzinga

Boston Scientific Stock Jumps On Q1 Earnings Beat, Improved Guidance ↗

April 28, 2021

Boston Scientific Corporation (NYSE: BSX) Q1 sales grew by 5.9% (organically) to $2.75 billion, beating the previous guidance range between negative...

Via Benzinga

Topics Earnings

Boston Scientific Corp (BSX) Q1 2021 Earnings Call Transcript ↗

April 28, 2021

BSX earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Boston Scientific: Q1 Earnings Insights ↗

April 28, 2021

Shares of Boston Scientific (NYSE:BSX) moved higher by 2.9% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 32....

Via Benzinga

Stocks That Hit 52-Week Highs On Friday ↗

April 23, 2021

On Friday morning, 152 companies hit new 52-week highs. Things to Consider: The largest company by market cap to hit a new 52-week high was ASML Holding (NASDAQ:...

Via Benzinga

Stock Market Rally Navigates Earnings From Apple, Tesla, Google, Facebook, Microsoft, Amazon ↗

April 30, 2021

The stock market rally navigated earnings from Apple, Tesla and the other "big six" market cap companies. Many breakouts, but not all succeeded.

Via Investor's Business Daily

Boston Scientific Earnings Beat, Guidance Raised; BSX Clears Buy Point ↗

April 28, 2021

Boston Scientific earnings beat views, with the medical products giant also raising full-year EPS guidance. BSX stock rose back into a buy zone.

Via Investor's Business Daily

Topics Earnings

Cramer Gives His Opinion On Snap, Cleveland-Cliffs And More ↗

April 22, 2021

On CNBC's "Mad Money Lightning Round," Jim Cramer said Snap Inc (NYSE: SNAP) is going to have a great quarter. It has tremendous growth and Cramer is a buyer. Regal...

Via Benzinga

The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx ↗

April 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:...

Via Benzinga

BOSTON SCIENTIFIC INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Boston Scientific Corporation - BSX

April 16, 2021

From Kahn Swick & Foti, LLC

Via Business Wire

The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping ↗

April 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc...

Via Benzinga

'Halftime Report' Final Trades: Apple, Nvidia And More ↗

April 15, 2021

On CNBC's 'Fast Money Halftime Report,' the investment committee gave their final trades of the day. Sand Hill Global Advisors’ Brenda Vingiello likes Apple Inc...

Via Benzinga

Return On Capital Employed Overview: Boston Scientific ↗

April 15, 2021

Boston Scientific (NYSE:BSX) posted a 124.76% decrease in earnings from Q3. Sales, however, increased by 1.84% over the previous quarter to $2.71 billion. Despite the increase in...

Via Benzinga

The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx ↗

April 24, 2021

Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:...

Via Benzinga

Stocks And ETFs To Buy Now - Sunday, April 11 ↗

April 11, 2021

This video discusses which stocks and ETFs to look at for the coming week. This video also discusses cash flow and options strategies.

Via Talk Markets

The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs ↗

April 23, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 22) AtriCure, Inc. (NASDAQ:...

Via Benzinga

These Lower Highs ↗

April 07, 2021

Here are eight charts that have exhibited a series of “lower highs”, which is indicative of trend change.

Via Talk Markets

The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs ↗

April 22, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 21) Alexion Pharmaceuticals,...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 15, 2021 ↗

April 15, 2021

Upgrades According to JP Morgan, the prior rating for Vipshop Holdings Ltd (NYSE:VIPS) was changed from Neutral to Overweight. In the fourth quarter, Vipshop Holdings...

Via Benzinga

< Previous 1 2

...

23 24 25 26 27 28 29 30 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.